Relief Therapeutics Holding AG (RLFTF)

[Uncle Gee Gee]

A few things in that article that jump out at me about Eli Lilly's drug...

1) You are correct... they need the 2-drug cocktail for better results:
"It expects to submit a request for emergency use authorization for the combination therapy next month, after patients are enrolled in clinical trials and supply has been manufactured."

2) Doesn't sound too convincing: "Lilly had previously released results for a similar treatment using one antibody, which experts viewed as promising. But the new results, of a combination of two antibodies, appear, based on limited data provided in a press release, to be more robust."

3) How quick and effective is it? "The patients in the study were sick with Covid-19, but had not been admitted to the hospital. Eli Lilly said that in a preliminary analysis the antibody combination reduced the amount of virus in nasal swabs of patients after 11 days."

4) Hmmm... "Key data, including the actual viral loads of patients and the makeup of the study population, were not included in the press release."

5) It does have promise, but only BOTH drugs... "The difference in viral load was statistically significant at day 11, unlike some doses of Lilly’s single-antibody cocktail."

6) It did reduce hospital visits, but... "That difference, however, was just barely statistically significant."